A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19

SARS-CoV-2 is the causative viral pathogen driving the COVID-19 pandemic that prompted an immediate global response to the development of vaccines and antiviral therapeutics. For antiviral therapeutics, drug repurposing allowed for rapid movement of existing clinical candidates and therapies into hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrimp, Jonathan H., Janiszewski, John, Chen, Catherine Z., Xu, Miao, Wilson, Kelli M., Kales, Stephen C., Sanderson, Philip E., Shinn, Paul, Itkin, Zina, Guo, Hui, Shen, Min, Klumpp-Thomas, Carleen, Michael, Samuel G., Zheng, Wei, Simeonov, Anton, Hall, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845423/
https://www.ncbi.nlm.nih.gov/pubmed/35169799
http://dx.doi.org/10.1101/2022.02.04.479134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845423/
https://www.ncbi.nlm.nih.gov/pubmed/35169799
http://dx.doi.org/10.1101/2022.02.04.479134

Ejemplares similares